Boston Scientific Senior Vice President Maulik Nanavaty sold 71,558 shares of company stock on May 29. The shares were sold at an average price of $18.52, for a total of $1.32 million.
Cantel Medical reported financial results for the third quarter of ended April 30, 2015. The Medivators endoscopy business delivered organic sales growth of 17 percent in the quarter
The underwriters participating in the EndoChoice initial public offering are exercising their option to purchase an additional 702,500 shares from the company, as well as 250,000 shares from certain selling stockholders. The shares were purchased at the public offering price of $15 per share.
EXACT Sciences stock received an average price target of $26.33. The 52-week high of the share price is $29.97 and the 52-week low is $14.71.
PAION, a specialty pharmaceutical company, initiated a second phase 3 clinical trial of its ultra-short-acting anesthetic Remimazolam.
Physicians Endoscopy acquired a minority interest in Garden State Endoscopy Center in Kenilworth, N.J. The company now has 40 centers.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
AbbVie strikes $1.19 billion collaboration deal with Halozyme, Ferring Pharmaceuticals expands into Russian market & more – 5 GI/endoscopy company key notes
American Journal of Gastroenterology features updates on biomarker advances
5 most-read GI/endoscopy stories – June 1 to June 5
